Travere Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | 4.3% | 4.3% | -117.6% |
| FY2012 | 890.4% | 890.4% | -1,268.9% |
| FY2013 | 176.1% | 176.1% | -168.9% |
| FY2014 | 297.8% | 297.8% | -81.9% |
| FY2015 | 39.1% | 39.1% | 22.9% |
| FY2016 | -15.6% | -15.6% | -9.1% |
| FY2017 | -20.4% | -20.4% | -11.5% |
| FY2018 | -32.3% | -32.3% | -14.5% |
| FY2019 | -66.2% | -66.2% | -24.2% |
| FY2020 | -80.2% | -80.2% | -27.9% |
| FY2021 | -59.6% | -59.6% | -23.2% |
| FY2022 | -649.9% | -649.9% | -41.4% |
| FY2023 | -55.5% | -55.5% | -14.1% |
| FY2024 | -544.3% | -544.3% | -54.1% |
| FY2025 | -22.2% | -22.2% | -4.2% |